Barbara Haley
The University of Texas Southwestern Medical Center(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Cancer Genomics and Diagnostics, Cancer Treatment and Pharmacology
Most-Cited Works
- → Circulating Tumor Cells in Patients with Breast Cancer Dormancy(2004)969 cited
- → Nanoparticles for drug delivery in cancer treatment(2008)787 cited
- → Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial(2020)594 cited
- → Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer(2016)546 cited
- → HER-2 gene amplification can be acquired as breast cancer progresses(2004)507 cited
- → Adaptive Randomization of Neratinib in Early Breast Cancer(2016)456 cited
- → Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation–Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105(2015)226 cited
- → Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results(2009)214 cited
- → Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102(2018)188 cited